HIV-1

This is a public group

  • Profile

    HIV-1 is spreading throughout the world at an alarming rate. Although there are drugs which can keep HIV-1 at bay but the disease has been designated as uncurable. The group aims to connect people actively working on this area and discuss on the recent developments in the related field.

    Admin contact:
    vikas sood
    Tags:
    molecular biology infectious diseases immunology viruses hiv aids
  • Notice board

  • Forum

  • Members'
    publications

    • Risk for HIV-1 infection is not associated with Repeat-Region polymorphism in the DC-SIGN neck domain and Novel Genetic DC-SIGN Variants among North Indians. Clinica chimica acta; international journal of clinical chemistry (2008) (Epub 12 Jan 2008) PubMed ID:(18255039)

    • Sood V, Unwalla H, Gupta N, Chakraborti S, Banerjea A. Potent knock down of HIV-1 replication by targeting HIV-1 Tat/Rev RNA sequences synergistically with catalytic RNA and DNA. AIDS (London, England) 21 (1) , 31-40 (2007) PubMed ID:(17148965)

    • Bano A, Gupta N, Sharma Y, Sood V, Banerjea A. HIV-1 VprB and C RNA cleavage by potent 10-23 DNAzymes that also cause reversal of G2 cell cycle arrest mediated by Vpr genes. Oligonucleotides 17 (4) , 465-72 (2007) PubMed ID:(18078383)

    • Bano A, Gupta N, Sood V, Banerjea A. Vpr from HIV-1 subtypes B and C exhibit significant differences in their ability to transactivate LTR-mediated gene expression and also in their ability to promote apoptotic DNA ladder formation. AIDS (London, England) 21 (13) , 1832-4 (2007) PubMed ID:(17690591)

    • Unwalla H, Chakraborti S, Sood V, Gupta N, Banerjea A. Potent inhibition of HIV-1 gene expression and TAT-mediated apoptosis in human T cells by novel mono- and multitarget anti-TAT/Rev/Env ribozymes and a general purpose RNA-cleaving DNA-enzyme. Antiviral research 72 (2) , 134-44 (2006) (Epub 08 Jun 2006) PubMed ID:(16790281)

    • Gupta N, Sood V, Bano A, Banerjea A. X Protein of hepatitis B virus potently activates HIV-1 subtype C long terminal repeat promoter: implications for faster spread of HIV-1 subtype C. AIDS (London, England) 21 (11) , 1491-2 (2007) PubMed ID:(17589200)

    • Sood V, Gupta N, Shanker V, Bano A, Banerjea A. Basal RANTES promoter activity differs considerably among different species of monkeys: implications for HIV-1/AIDS progression. AIDS (London, England) 21 (1) , 116-8 (2007) PubMed ID:(17148981)

    • Sood V, Gupta N, Bano A, Banerjea A. DNA-enzyme-mediated cleavage of human immunodeficiency virus type 1 Gag RNA is significantly augmented by antisense-DNA molecules targeted to hybridize close to the cleavage site. Oligonucleotides 17 (1) , 113-21 (2007) PubMed ID:(17461768)

    Group members can post their publications here from their profile page.

  • Recently
    joined


Search groups

Create a group web feed

Advertisement